Poly(ADP-ribose) polymerase (PARP) plays a major role in single-strand DNA repair, and PARP inhibitors have demonstrated antitumor activity in HER2-negative metastatic breast cancer patients, associated with BRCA1/2 germline mutations. The gene discussed is BRCA1; the disease is breast cancer.